Table 3.

Haemolysis and platelet aggregation measured upon the contact of the blood or platelet-rich plasma with vascular grafts.

Graft Type	Haemolysis, % Median (IQR)	Maximum Platelet Aggregation, % Median (IQR)
Platelet-rich plasma	-	14.61 (13.63–17.72)
PHBV/PCL[VEGF-bFGF-SDF]	0 (0–0)	17.25 (16.30–17.96)
PHBV/PCL[VEGF-bFGF-SDF]Hep/Ilo	0.36 (0.36–0.36) **	8.22 (8.13–8.78) *
ePTFE	0.33 (0.21–2.40) **	22.74 (22.45–24.52)

PHBV/PCL—poly(3-hydroxybutyrate-co-3-hydroxyvalerate), PCL—poly(ε-caprolactone), [VEGF-bFGF-SDF]—combination of vascular endothelial growth factor, basic fibroblast growth factor and stromal cell-derived factor 1α, Hep/Ilo—modification with heparin and iloprost, ePTFE—expanded poly(tetrafluoroethylene), IQR—interquartile range. * p < 0.05 compared with platelet-rich plasma, PHBV/PCL[VEGF-bFGF-SDF] and ePTFE grafts, ** p < 0.05 compared with platelet-rich plasma and PHBV/PCL[VEGF-bFGF-SDF] grafts.